More Company News

Redx Pharma

Encouraging RXC004 Phase I data in advanced solid tumours
20 Sep 2021Read More

Redx Pharma

RXC004 Phase I monotherapy data to be presented at ESMO 2021
15 Sep 2021Read More

Redx Pharma

Milestone payment from Jazz Pharmaceuticals
02 Sep 2021Read More

Redx Pharma

Phase II dose selection of RXC004
27 Jul 2021Read More

Redx Pharma

Receipt of $4m RXC004 milestone payment
17 Jun 2021Read More

Redx Pharma

Interim H121 results
07 Jun 2021Read More

Redx Pharma

First subject dosed in RXC007 Phase I study
03 Jun 2021Read More

Redx Pharma

Appointment of Peter Collum as CFO
05 May 2021Read More

Redx Pharma

First patients dosed with RX004 and anti-PD-1
28 Apr 2021Read More

Redx Pharma

FY20 results and operational update
27 Jan 2021Read More

1 2
Return to Redx Pharma
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).